Chromosomal amplification of the blaOXA-58 carbapenemase gene in a Proteus mirabilis clinical isolate

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 2, 2017, Pages

  Girlich, Delphine ^a,b   Bonnin, Rémy A ^a,b   Bogaerts, Pierre ^c,d   De Laveleye, Morgane ^d   Huang, Daniel T ^c,d   Dortet, Laurent ^a,b   Glaser, Philippe ^a,e   Glupczynski, Youri ^c,d   Naas, Thierry ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Assoc Fr Natl Ref Center for Antibiotic Resistance: Carbapenemase Producing Enterobacteriaceae   (France)

^c Belgian National Reference Center for Monitoring Antimicrobial Resistance in Gram negative Bacteria   (Belgium)

^d CHU UCL NAMUR   (Belgium)

^e CNRS   (France)

Author keywords

Acinetobacter baumannii; Bacteriophage; Carbapenems; OXA 58; Proteus mirabilis; XerC XerD recombinase

Indexed keywords

AMOXICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TEMOCILLIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN; INTEGRASE; XERC PROTEIN, E COLI; XERD PROTEIN, E COLI;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BINDING SITE; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME; COLORECTAL CARCINOMA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEVER; GENE AMPLIFICATION; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HYDROLYSIS; LOWER ABDOMINAL PAIN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROPHAGE; PROTEUS MIRABILIS; SOUTHERN BLOTTING; WHOLE GENOME SEQUENCING; BACTERIAL CHROMOSOME; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIGENE FAMILY; PROTEUS INFECTIONS;

ADULT; BACTERIAL PROTEINS; BETA-LACTAMASES; BINDING SITES; CHROMOSOMES, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INTEGRASES; MALE; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; PROPHAGES; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 85010943857     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01697-16     Document Type: Article

References (33)

1. Burgess DJ. 2014. Bacterial genetics: amplified origins of antibiotic resistance. Nat Rev Microbiol 12:394. https://doi.org/10.1038/nrmicro3275.
2. Beceiro A, Tomás M, Bou G. 2013. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev 26:185-230. https://doi.org/10.1128/CMR.00059-12.
3. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269-284. https://doi.org/10.1038/nrmicro3432.
4. Villar HE, Danel F, Livermore DM. 1997. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams. J Antimicrob Chemother 40:365-370. https://doi.org/10.1093/jac/40.3.365.
5. Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. 2008. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis. J Clin Microbiol 46:3080-3083. https://doi.org/10.1128/JCM.00979-08.
6. Hu Y, Cai J, Zhang R, Zhou H, Sun Q, Chen G. 2012. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese hospital. Antimicrob Agents Chemother 56:2278-2282. https://doi.org/10.1128/AAC.05519-11.
7. Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Pournaras S, Markou F. 2007. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 60:136-139. https://doi.org/10.1093/jac/dkm138.
8. Girlich D, Dortet L, Poirel L, Nordmann P. 2015. Integration of the blaNDM-1 carbapenemase gene into Proteus genomic island 1 (PGI1-PmPEL) in a Proteus mirabilis clinical isolate. J Antimicrob Chemother 70:98-102. https://doi.org/10.1093/jac/dku371.
9. Chen L, Al Laham N, Chavda KD, Mediavilla JR, Jacobs MR, Bonomo RA, Kreiswirth BN. 2015. First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine. Antimicrob Agents Chemother 59:4305-4307. https://doi.org/10.1128/AAC.00565-15.
10. Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J. 2002. Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother 46:2004-2006. https://doi.org/10.1128/AAC.46.6.2004-2006.2002.
11. Österblad M, Karah N, Halkilahti J, Sarkkinen H, Uhlin BE, Jalava J. 2016. Rare detection of the Acinetobacter class D carbapenemase blaOXA-23 gene in Proteus mirabilis. Antimicrob Agents Chemother 60:3243-3245. https://doi.org/10.1128/AAC.03119-15.
12. Bonnin RA, Nordmann P, Poirel L. 2013. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther 11:571-583. https://doi.org/10.1586/eri.13.38.
13. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. 2006. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol 44:3318-3324. https://doi.org/10.1128/JCM.00756-06.
14. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 54:24-38. https://doi.org/10.1128/AAC.01512-08.
15. Bonnin RA, Poirel L, Benoit-Cattin T, Nordmann P. 2013. Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago. Int J Antimicrob Agents 41:297-298. https://doi.org/10.1016/j.ijantimicag.2012.11.002.
16. Dortet L, Bréchard L, Poirel L, Nordmann P. 2014. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol 63:772-776. https://doi.org/10.1099/jmm.0.071340-0.
17. Bogaerts P, Yunus S, Massart M, Huang T-D, Glupczynski Y. 2016. Evaluation of the BYG Carba test, a new electrochemical assay for rapid laboratory detection of carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 54:349-358. https://doi.org/10.1128/JCM.02404-15.
18. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. https://doi.org/10.1093/jac/dks261.
19. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. https://doi.org/10.1186/1471-2164-9-75.
20. Krizova L, Maixnerova M, Sedo O, Nemec A. 2014. Acinetobacter bohemicus sp. nov. widespread in natural soil and water ecosystems in the Czech Republic. Syst Appl Microbiol 37:467-473. https://doi.org/10.1016/j.syapm.2014.07.001.
21. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. https://doi.org/10.1016/0147-619X(84)90063-5.
22. Midonet C, Barre FX. 2014. Xer site-specific recombination: promoting vertical and horizontal transmission of genetic information. Microbiol Spectr 2(6). https://doi.org/10.1128/microbiolspec.MDNA3-0056-2014.
23. Kono N, Arakawa K, Tomita M. 2011. Comprehensive prediction of chromosome dimer resolution sites in bacterial genomes. BMC Genomics 12:19. https://doi.org/10.1186/1471-2164-12-19.
24. Romero D, Palacios R. 1997. Gene amplification and genomic plasticity in prokaryotes. Annu Rev Genet 31:91-111. https://doi.org/10.1146/annurev.genet.31.1.91.
25. Brochet M, Couvé E, Zouine M, Poyart C, Glaser P. 2008. A naturally occurring gene amplification leading to sulfonamide and trimethoprim resistance in Streptococcus agalactiae. J Bacteriol 190:672-680. https://doi.org/10.1128/JB.01357-07.
26. Feng Y, Yang P, Wang X, Zong Z. 2016. Characterization of Acinetobacter johnsonii isolate XBB1 carrying nine plasmids and encoding NDM-1, OXA-58 and PER-1 by genome sequencing. J Antimicrob Chemother 71:71-75. https://doi.org/10.1093/jac/dkv324.
27. Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, Bou G. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother 54:2724-2727. https://doi.org/10.1128/AAC.01674-09.
28. Dortet L, Fusaro M, Naas T. 2016. Improvement of the Xpert Carba-R kit for the detection of carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 60:3832-3837. https://doi.org/10.1128/AAC.00517-16.
29. Kabir MH, Meunier D, Hopkins KL, Giske CG, Woodford N. 2016. A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. J Antimicrob Chemother 71:1213-1216. https://doi.org/10.1093/jac/dkv468.
30. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351-353. https://doi.org/10.1016/j.ijantimicag.2006.01.004.
31. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. 2011. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55:2420-2423. https://doi.org/10.1128/AAC.01452-10.
32. Marck C. 1988. "DNA Strider": a "C" program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res 16:1829-1836. https://doi.org/10.1093/nar/16.5.1829.
33. Villion M, Szatmari G. 2003. The XerC recombinase of Proteus mirabilis: characterization and interaction with other tyrosine recombinases. FEMS Microbiol Lett 226:65-71. https://doi.org/10.1016/S0378-1097(03)00577-9.